Get all your news in one place.
100's of premium titles.
One app.
Start reading
Evening Standard
Evening Standard
Business
Jeremy Cutler

UNCOVERED: Ftse 100 held back by astrazeneca trial setback | History Defined

The pharmaceutical firm sank 6.2% (Peter Byrne/PA) - (PA Archive)

Heavy falls in AstraZeneca saw London’s FTSE 100 underperform European peers, while investors continue to weigh up developments in the Middle East.

The FTSE 100 closed down 16.59 points, 0.2%, at 10,472.45. The FTSE 250 ended up 222.92 points, 1.0%, at 23,240.56, while the AIM All-Share rose 4.18 points, 0.6%, to 762.25.

Sign up to read this article
Read news from 100's of titles, curated specifically for you.
Already a member? Sign in here
Related Stories
Top stories on inkl right now
One subscription that gives you access to news from hundreds of sites
Already a member? Sign in here
Our Picks
Fourteen days free
Download the app
One app. One membership.
100+ trusted global sources.